Tokyo: Life Sciences and Health Care Horizons 2019

Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.

Tokyo: Life Sciences and Health Care Horizons 2019

Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.

New Era of Offshore Wind Power Projects in Europe, Japan, and the U.S.

Japan is the latest country to pass a new law, “the Act regarding the Promotion of Use of Sea Areas to Develop Offshore Renewable Energy Facilities" (Saiene Kaiiki Riyou Hou), to ...

Exciting Trends in Japanese Tech M&A

In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...

Exciting Trends in Japanese Tech M&A

In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...

Going Global 2018

Cross-practice, multi-track seminar on advanced trademark issues, global M&A transactions, global patent updates for technology companies, energy investments, and recent...

Loading data